TALPHERA, INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
1850 GATEWAY DRIVE, SAN MATEO, CA, 94404
Mailing Address
1850 GATEWAY DRIVE, SAN MATEO, CA, 94404
Phone
650-216-3500
Fiscal Year End
1231
EIN
412193603
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | March 25, 2026 | View on SEC |
| 4 Insider stock transaction report | March 25, 2026 | View on SEC |
| 10-K Annual financial report | March 23, 2026 | View on SEC |
| 8-K Current report of material events | March 23, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 8-K Current report of material events | March 16, 2026 | View on SEC |
Annual Reports
10-K
March 23, 2026
- TALPHERA, INC. strategically exited its DSUVIA business, receiving an upfront payment of $5 million and potential future milestones.
- Secured $10.0 million in post-year-end private placement funding, selling 1,000,000 common shares and 9,000,000 prefunded warrants.
Material Events
8-K
Financial Distress
March 13, 2026
High Impact
- TALPHERA, INC. received a formal Nasdaq delisting warning.
- The primary reason is its stock price consistently trading below $1.00 per share.
Insider Trading
BUY
4 insiders
5 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.